Current Prices from NeuroSense Therapeutics Ltd. - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NRSN	USD	13.06.2025 19:59	2,36 USD	2,40 USD -1,59 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-2,48 %	31,84 %	114,56 %	111,43 %	153,76 %	129,13 %	-41,58 %

Company Profile for NeuroSense Therapeutics Ltd. - Ordinary Shares Share

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Company Data

Name NeuroSense Therapeutics Ltd. - Ordinary Shares

Company NeuroSense Therapeutics Ltd.

Symbol NRSN

Website https://www.neurosense-tx.com

Primary Exchange

NASDAQ

ISIN IL0011809592

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Alon Ben-Noon

Market Capitalization 25 Mio

Country Israel

Currency USD

Employees 0,0 T

Address Building B, 4672562 Herzliya

IPO Date 2021-12-09

Ticker Symbols

Name	Symbol
Frankfurt	H1Z.F
NASDAQ	NRSN

More Shares

Investors who NeuroSense Therapeutics Ltd. - Ordinary Shares hold also have the following shares in their portfolio:

NESTLE SA CDR CDHREGS Share

TEJON RANCH CO Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog